No recent analyst price targets found for CURE.
Latest News for CURE
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity
The Direxion Daily Healthcare Bull 3X ETF (CURE) has slipped in early 2026 as investors take profits after a strong performance in late 2025. The correction in healthcare stocks comes even as analysts envisage significant gains for CURE's ten largest holdings over the next 12 months. This dynamic may present an opportunity to rotate into CURE from the unlevereged XLV ETF, which tracks the same underlying index.
Which Sector Topped the Leaderboard for January Returns?
The first month of 2026 is already in the books. Which sector walked away with the top spot when it came to total returns?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CURE.
U.S. House Trading
No House trades found for CURE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.